We are pleased to announce that registration is now open for the seventh annual MedStar Health Research Symposium on Monday, April 30, 2018, from 1:30 to 6:30 pm at the Bethesda North Marriott Hotel and Conference Center.
MedStar Health Collaborates with Inivata to Advance Precision Cancer Genomics Using Liquid Biopsy
MedStar Health is pleased to announce a collaboration with Inivata, a global clinical cancer genomics company using an industry-leading liquid biopsy platform to transform patient care. With the collaboration, MedStar Health, and specifically the MedStar Georgetown Cancer Institute, will join the Inivata Knowledge Accumulation Network (IKAN).
Medstar Researcher Interviewed on Work on MD Hospital Payment Reform
Published in Leader’s Edge magazine, Jessica Galarraga, MD, MPH, was interviewed with Jesse Pines, MD on their research into Maryland’s payment reform policies, specifically their work on global budget and the impact on both the hospital and the patient.
Neil Weissman, MD, Appointed MedStar Health System’s First Chief Scientific Officer
To support the MedStar Health’s further development as a nationally recognized Academic Health System, Neil J. Weissman, MD, has been appointed MedStar’s first Chief Scientific Officer. Dr. Weissman will continue to serve as President of MedStar Health Research Institute. As chief scientific officer, he will provide leadership for the development and implementation of scientific priorities, with a commitment to further advancing MedStar Health as an academic healthcare system.
Echocardiography Standardization Study Enrolls Landmark Number of Participants
Federico M. Asch, MD, FASE, is a co-principal investigator on the World Alliance of Societies of Echocardiography (WASE) Normal Values Study. The WASE study seeks to identify 100 participants in 17 counties to expand the definition of “normal” in echocardiography across a diverse population. The study currently has 1,000 enrolled participants, with individuals from six continents.